AI Science Tracker
EN

Development of a prognostic prediction signature for idiopathic pulmonary fibrosis by integrating multiple programmed cell death-related genes and machine learning algorithms.

the First Affiliated Hospital of Xi'an Jiaotong University; Key Laboratory of Enhanced Recovery After Surgery of Intergrated Chinese and Western Medicine; The First Affiliated Hospital of Xi'an Jiaotong University · 26 Sep 2025 · chemistry

Discovery

Development of a prognostic prediction signature for idiopathic pulmonary fibrosis by integrating multiple programmed cell death-related genes and machine learning algorithms.

Source check: Source checked. Not independent scientific confirmation.

Finding: Machine-learning/LASSO analysis across five GEO datasets selected seven cell-death-related IPF prognostic biomarkers and assessed the signature with external datasets; drug predictions are computational hypotheses, not treatment efficacy. Testing: Machine-learning/LASSO analysis across five GEO datasets selected seven cell-death-related IPF prognostic biomarkers and assessed the signature with external datasets; drug predictions are computational hypotheses, not treatment efficacy.. Source affiliation was not stated in the reviewed case checks and was unavailable in the local bibliographic cache.

Technology: Machine-learning/LASSO analysis across five GEO datasets selected seven cell-death-related IPF prognostic biomarkers and assessed the signature with external datasets; drug predictions are computational hypotheses, not treatment efficacy.

Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.

AI contribution
Machine-learning/LASSO analysis across five GEO datasets selected seven cell-death-related IPF prognostic biomarkers and assessed the signature with external datasets; drug predictions are computational hypotheses, not treatment efficacy.
Test and result
Machine-learning/LASSO analysis across five GEO datasets selected seven cell-death-related IPF prognostic biomarkers and assessed the signature with external datasets; drug predictions are computational hypotheses, not treatment efficacy.
Limitation / still unknown
Generalizability beyond the reported study population, data, and protocol was not established in the reviewed material.
Evidence sources and annotation context

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

Evidence sources: https://pmc.ncbi.nlm.nih.gov/articles/PMC12557667/ · https://europepmc.org/article/MED/41158409

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.

Review date: 22 Nov 2026. Review scope: Primary result-bearing material for the stated method, result and evaluation, with bibliographic version information..

No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.

Editorial assessment: Impact 3/5 · Validation 2/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Open in the full catalog for filters, charts and related discoveries. Browse chemistry discoveries.